Bluetongue disease is a viral illness that affects sheep, cattle, goats, deer, and other ruminants. It does not infect humans. The disease is spread by tiny biting midges (not mosquitoes), and it gets its name from the swollen, bluish tongue that can appear in severely affected sheep. While cattle often carry the virus with few visible signs, sheep bear the worst of it, with outbreaks capable of killing tens of thousands of animals in a single season.
How the Virus Spreads
Bluetongue virus (BTV) belongs to a group called orbiviruses, and at least 29 distinct serotypes have been identified worldwide, each with its own strain variations. The virus cannot spread directly from one animal to another. Instead, it relies entirely on Culicoides biting midges, insects barely 1 to 3 millimeters long, to carry it between hosts.
The cycle works like this: a midge feeds on the blood of an infected animal, picks up the virus, and then passes it along when it bites another animal days later. Transmission from an infected midge to a new host is extremely efficient. Going the other direction, however, is much harder. Only a small fraction of midges actually become infected after feeding on a sick animal, because the virus has to break through a barrier in the midge’s gut before it can reach the salivary glands and be passed on.
Different midge species dominate in different regions. In North America, Culicoides sonorensis is the primary carrier. In Europe, several species play a role, with Culicoides imicola being prominent in southern regions and species like Culicoides obsoletus and Culicoides scoticus active farther north. Temperature matters enormously: the virus needs a minimum of 10 to 15°C to replicate inside the midge, which is why bluetongue has historically been a warm-climate disease. As average temperatures rise, though, outbreaks have pushed into northern Europe and other previously unaffected areas.
Symptoms in Sheep and Cattle
After an animal is bitten by an infected midge, symptoms typically appear within 4 to 8 days. The disease hits sheep hardest. Early signs include high fever (up to 42°C), facial swelling, and a runny nose. As the infection progresses, sheep may develop excessive drooling, ulcers on the tongue and inside the mouth, and lameness caused by inflammation around the hooves (a condition called coronitis). In severe cases, blood vessel damage and oxygen deprivation cause the tongue to swell and turn a dusky blue, the hallmark sign that gave the disease its name. That blue tongue is actually rare, though, and only seen in the most serious infections.
Cattle present a very different picture. They usually experience mild symptoms or none at all, acting as silent carriers. Cattle do not develop the cyanotic tongue. What makes cattle particularly important is that they can remain infectious for longer periods, sometimes up to 60 days, serving as a reservoir that keeps the virus circulating in an area even when sheep are dying from it.
Goats and wild ruminants like deer and antelope can also be infected but generally experience milder disease, similar to cattle. The severity of any outbreak depends heavily on which of the 29 serotypes is involved. The BTV-3 strain that swept through the Netherlands, for example, caused over 65,000 excess sheep deaths during the 2024 epidemic alone.
Economic Toll on Farmers
Bluetongue’s financial damage extends well beyond dead animals. Infected dairy cattle in one Tunisian outbreak showed daily milk production drops of 12.5 to 14.7 liters per cow, lasting an average of five months. Diseased sheep lost 4 to 10 kilograms of body weight during outbreaks. In Germany, direct losses per infected animal ranged from €119 to €136, covering costs like replacement animals, veterinary treatment, reduced milk output, and lost calf sales. Across studied farms in Tunisia, a single 2020 outbreak cost an estimated €561 million.
Milk loss, animal deaths, and veterinary bills are the three biggest cost drivers. But those are only the farmer-level expenses. Government spending on surveillance, trade restrictions, diagnostics, and vector monitoring often exceeds what farmers themselves lose. When a country reports bluetongue, international trade in live animals and animal products from affected regions can be restricted, creating ripple effects through entire livestock industries.
No Risk to Humans
Bluetongue is not a zoonotic disease. There is no known risk of human infection with the virus, and meat and milk from affected animals are safe to consume. While bulk milk testing is sometimes used as a surveillance tool to monitor how widely the virus has spread in cattle herds, this is purely an animal health measure, not a food safety concern.
How Bluetongue Is Diagnosed
Veterinarians diagnose bluetongue through a combination of clinical signs and laboratory testing. Blood samples from suspected animals are the primary diagnostic material. The fastest and most reliable method is real-time RT-PCR, a molecular test that detects the virus’s genetic material directly. It is highly sensitive and can identify the virus in various sample types within hours.
Serological tests, which look for antibodies rather than the virus itself, are used to confirm past exposure or screen herds. A competitive ELISA is the most widely trusted serological method. Virus isolation, where the pathogen is grown in cell cultures or embryonated chicken eggs, remains the gold standard for confirmation but takes considerably longer.
Vaccination and Prevention
Vaccination is the primary tool for controlling bluetongue, but it comes with a significant challenge: immunity is serotype-specific. A vaccine against serotype 4 will not protect against serotype 8 or serotype 3. This means authorities need to identify which serotype is circulating before they can deploy the right vaccine, and regions facing multiple serotypes may need multiple vaccination campaigns.
Two main vaccine types are in use. Inactivated vaccines, made from killed virus, are the most commonly used because they carry the lowest safety risks. Live attenuated vaccines, which use a weakened form of the virus, generate stronger immune responses but come with a moderate risk of the vaccine strain reverting to a form that can cause disease. Some countries prohibit their use for this reason. Newer approaches like the DISA vaccine, which deletes a gene responsible for the virus spreading through the bloodstream, are in development but not yet commercially available.
Beyond vaccination, outbreak control relies on restricting animal movement within and out of affected zones, culling infected animals in some cases, and reducing midge populations where possible through insecticide use and habitat management. Keeping livestock indoors during peak midge activity, typically around dawn and dusk, can also reduce exposure. Preventive and control measures at the government level consistently cost more than the production losses the disease itself causes, but the alternative, an uncontrolled spread, is far more expensive.